Nabla Bio
AI-driven generative platform for de novo design of drug-like antibodies and medicines using integrated patient-relevant testing.
ツール情報
Nabla Bioとは何ですか?
Nabla Bio is an AI-driven generative platform that makes drug development a true design discipline. It combines generative de novo drug design with large-scale human-relevant testing and integrated dry/wet-lab systems to produce safer, more precise medicines that reach patients faster.
コア機能
Generative de novo drug design
AI-powered generation of drug candidates, including drug-like antibodies, directly from computational methods.
Patient-relevant testing integration
Combines generative design with large-scale human-relevant testing to convert trial-and-error discovery into engineerable success.
Integrated dry/wet-lab engine
Owns and unifies data, AI models, and dry/wet-lab systems to design medicines targeting binding, developability, cellular function, and in-vivo performance.
JAM-2 antibody generation
Produces drug-like antibodies straight from the computer as part of the generative design pipeline.
使用例
- #1
Pharmaceutical partnership drug design
Collaborative design of new medicines with leading pharmaceutical companies to bring safer and more precise drugs to patients.
- #2
Antibody and target expansion
Design of novel antibodies and medicines that unlock new targets and expand treatment frontiers.
代替案
よくある質問
What is Nabla Bio?
What does Nabla Bio's JAM-2 technology do?
Who does Nabla Bio partner with?
Where is Nabla Bio based?
Is pricing information available for Nabla Bio?
Nabla Bio 連絡先とソーシャルメディア
- 会社Nabla Bio, Inc
- 住所Riverside Technology Center 840 Memorial Dr Cambridge, MA 02139
- サポートメール
- ウェブサイト:
- Twitter
- LinkedIn
レビュー
このツールの使用経験を共有してください...